Michael Dybbs serves as Executive at Dimension Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael Dybbs has executed 3 insider transactions totaling $12.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 5, 2026 involved receiving (via award) 27,400 shares valued at $0.
Michael Dybbs currently holds 27,400 shares of Dimension Therapeutics, Inc. (DMTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Dybbs has been a net buyer of DMTX stock. They have purchased $12.5M and sold $0 worth of shares.
Michael Dybbs's most recent insider trade was on Feb 5, 2026, when they sold 27,400 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 27, 2015 | DMTX | $12.5M | Purchase | 961,538 | $13.00 | Discretionary |